Manatt Health January 31, 2024
Editor’s Note: The article below is the second in our three-part series, Federal Antitrust Enforcement in Health Care: 2023 Year in Review. (Click here to read part 1.) The series is based on our recent webinar, 2023 Health Care Enforcement Trends: Spotlight on Consumer Protection, Antitrust and Fraud. Click here to view the free webinar on demand.
Merger challenges in pharmaceuticals, medtech and devices received a lot of attention and resources at the Federal Trade Commission (FTC) and State Attorneys General in 2023. Success in several high profile enforcement actions was in many ways a preview of coming attractions in the antitrust arena, as enforcers focus on industry-changing deals and make an effort to address what they perceive as historical...